根据全球50家大型制药企业的所有重磅生物制药（销售超过10亿美元的产品）建模推算，2013年全球重磅生物制药总销售额达1420亿美元，年增长率为9.1%，预计2014年全球销售额将逼近1500亿美元。重磅生物制药行业的市场前景颇为乐观，研究人士表示，“现有产品远远不能充满整个市场空间”。在国内，生物医药产业也正风生水起，多地纷纷加快发展生物医药产业的步伐。据预计，在未来三年内，中国生物产业产值的年增长率将高达20%，在相关领域的投资额将超过3000亿美元，而该领域也将成为利润丰厚的投资领域之一。

由欧洲博闻展览咨询有限公司(UBM Live)和中国医药保健品进出口商会主办，上海博华国际展览有限公司（UBM Sinoexpo） 协办的2015生物制药与技术中国展(BioPh China 2015) 将在2015年6月24-26日在上海新国际博览中心举行。

生物技术与制药中国展契合生物制药行业蓬勃发展的趋势，聚焦生物科技、临床试验，集中展示基因工程、抗体工程、细胞培养、生物仪器等产品与技术，为制药制药公司、新药研发企业及专业人士提供最佳的贸易交流平台，助力生物制药市场的无限商机。甘李药业、长春金赛、沈阳三生、东宝实业、深圳迈高、厦门特宝等知名企业将作为展商参与本次展会。

2015第二届Bioph中国生物制药峰会将与生物制药中国展同期举办，聚集来自生物医药、生物科技、权威法规部门、风险投资等相关领域顶尖专家，聚焦国内法规更新、全球市场机遇与挑战以及技术优化与创新三大板块与主题，深入解读最新注册与审批政策，探讨全球市场融合下的创新合作模式、优化关键技术加速产业化进程等热点内容，致力于为行业从业者提供一个分享研发经验和案例分析的绝佳平台，通过促进交流与合作，充分挖掘中国生物制药市场的无限可能。

2015生物制药中国展将进一步加强与海外医药企业间的沟通与合作，培育品牌、提升技术、构建渠道，为全面推动中国生物制药行业发展做出更大的贡献。

2014 Global Sales of Blockbuster Biologics Expected to Approach $150 Billion

It is estimated that the total sales of blockbuster biologics of global top 50 pharmaceutical companies has reached 140 billion US dollars, with a yearly growth rate of 9.1%. 2014 is expected to approach 150 billion US dollars. The global biopharmaceutical market sees a rosy prospect. Researchers suggested that the existing products are far from the whole market capacity. In China, the biopharmaceutical industry is also developing at an accelerated pace. China’s growth rate of bio-industry output value is estimated to reach 20% within three years. Investment in related fields will exceed 300 billion US dollars. Biopharma will also become one of the highest profit industries.

BioPh Expo China 2015, organized by UBM Live and CCCMHPIE and supported by UBM Sinoexpo, will be held on 24-26 June 2015 in Shanghai New International Expo Centre.

BioPh Expo China focuses on biotechnology and related fields offering an ideal platform for biopharma companies, drug discovery organizations, pharma manufacturers and scientific research institutions to create new partnerships and discuss the latest topics. All companies and organizations dealing with the research and development of new treatment methods made through biotechnological processes or which are derived from or use live organisms benefited from the exhibition. Well-known enterprises like Gan&Lee, GeneScience, Sunshine, Dongbao, Mellow Hope, Amoytop, etc. will attend this event as exhibitors.

2015 BioPh Summit China, concurrent with BioPh Expo, will bring together top experts and scientists from biopharma, biotechs, legislation, venture capital, etc. as well as leading technology solution providers from all over Asia and the rest of the world. Topics cover the latest regulations, current global biopharma market conditions ,opportunities and challenges, and crucial aspects of biopharma technology in China. It provides a platform to share research developments, case studies, best practices and discuss the challenges regarding the biopharmaceutical industry to unlock the potential of the huge market.

BioPh Expo China 2015 will continue to further improve the relationship with overseas pharmaceutical enterprises in brand building, technique promotion and channel construction for China’s biopharmaceutical industry development.